J Biol Chem, Vol. 275, Issue 13, 9403-9409, March 31, 2000
Cloning and Expression of the Bioluminescent Photoprotein
Pholasin from the Bivalve Mollusc Pholas dactylus*
Sarah L.
Dunstan
,
Graciela B.
Sala-Newby§,
Alexandra
Bermúdez
Fajardo
,
Kathryn M.
Taylor, and
Anthony K.
Campbell¶
From the Department of Medical Biochemistry, University of Wales
College of Medicine, Heath Park,
Cardiff CF14 4XN, United Kingdom
 |
ABSTRACT |
Pholasin is the photoprotein responsible for
luminescence in the bivalve Pholas dactylus and consists of
a luciferin tightly bound to a glycosylated protein. It is a sensitive
indicator of reactive oxygen species. A full-length clone encoding
apopholasin was isolated from a P. dactylus light organ
cDNA library. The unprocessed apoprotein contained 225 amino acids,
starting with a signal peptide of 20 amino acids, 3 predicted
N-linked glycosylation sites, 1 O-linked site,
no histidines, and 7 cysteines. The recombinant apoprotein was
expressed in cell extracts and insect cells. The size of the apoprotein
expressed in cell extracts and the cytosol of insect cells was 26 kDa
but that of the fully processed protein was 34 kDa, as was native
pholasin. Both the processed and unprocessed recombinant apoproteins
were recognized by a polyclonal antibody raised against native
pholasin. Acid methanol extracts from Pholas added to
recombinant apoprotein resulted in chemiluminescence triggered by
sodium hypochlorite but not photoprotein formation. These results have
important implications in understanding the molecular evolution of
bioluminescence and will allow the development of recombinant pholasin
as an intracellular indicator of reactive oxygen species.
 |
INTRODUCTION |
Pholas dactylus is a marine, rock-boring, bivalve
mollusc, which squirts a blue, luminous secretion (
max
490 nm) from its siphon when disturbed. Its luminescence has been known
since ancient times (1) and has an historic place in the biochemistry
of bioluminescence, since it was the first organism used to describe the oxygen-requiring luciferin-luciferase reaction that is universal in
bioluminescence (2). In fact, the "luciferin" from
Pholas that Dubois named is a photoprotein containing the
luciferin, a small organic molecule that is the true light emitter.
However, the precise chemistry of the luminescence and its evolutionary origin are unknown.
Pholas is essentially a European species, being common in
soft, sedimentary rocks along the south coast of United Kingdom from
Folkestone to Plymouth and is also found in the Severn estuary. It also
occurs in substantial numbers along the French coast, particularly
Brittany, and in the Mediterranean. The adult mollusc lives its entire
life buried in soft rock and can only be collected at a good spring
tide. At night the majority of organisms are seen as a starlight
display in rocks never exposed at low water. Light emission has been
observed in the wild to change during the lunar cycle, being difficult
to provoke at full moon.1 It
is not known whether Pholas luminescence follows a circadian rhythm as do many other luminous organisms (1, 3, 4).
The two main components of the luminescent reaction, pholasin and
Pholas luciferase, are found in triangular light organs on
the surface of the muscles and in light cords along the edge of the
siphon (5, 6). The luciferase is a 150-kDa copper-containing enzyme
with peroxidase-like properties (7). Pholasin consists of a luciferin
(a small organic moiety) bound tightly to an apoprotein and binds to
the luciferase to generate light in the presence of oxygen (Equation 1)
(7-9).
|
(Eq. 1)
|
However, pholasin alone generates a continuously weak glow
(k = 8.12 ± 0.87 × 10
6
s
1). Pholasin chemiluminescence can be enhanced up to 1 million times by addition of its luciferase or enzymes that can
generate reactive oxygen species (8). Pholasin, like aequorin, is a photoprotein (1, 10); the total light emitted is directly proportional
to the amount of luminescent protein present. Thus, unlike a normal
enzyme, pholasin turns over only once (Equation 2).
|
(Eq. 2)
|
Pholasin chemiluminescence provides an indicator for
ROS2 in biological systems,
such as the superoxide released by neutrophils as a result of the
oxidative burst. Pholasin has been proved to be a very sensitive
indicator, capable of measuring the oxidative burst of one phagocyte
(8), or the intracellular oxidative stress of a single myocyte (11).
Measurement of ROS in vivo should be a valuable tool to
study the involvement of ROS in many pathological conditions including
cancer (12) and Alzheimer's disease (13) and also in apoptosis (14,
15), the regulation of phosphorylation events (16) and in aging
(17-19).
We have cloned, sequenced, and expressed the apoprotein of pholasin. We
reconstituted the luminescent protein using putative luciferin isolated
from Pholas. The lack of overall sequence similarity with
all the other known luminescent proteins suggests that
Pholas luminescence is another example of the independent
evolution of bioluminescence.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Live specimens of P. dactylus were
collected at Charmouth Beach, Dorset, UK, during periods of low tide
and kept in filtered seawater at 8-10 °C. Oligonucleotide primers
were prepared using an Applied Biosystems 392 DNA synthesizer and
purified as "trityl off." All degenerate oligonucleotides (the
degenerate oligonucleotides used are: I, inosine; N, any base; H,
A/C/T; R, A/G; and Y, C/T) were obtained from Perkin-Elmer Applied
Biosystems. The degenerate oligonucleotides 1, ACI ATH TTY TTY CAR GT;
2, CAR GAR GAR GGN ACI GA; 2A, TCI GTN CCY TCY TCY TG; and N-term, TTY
AAY GTI GAY TGG ATG hybridized to the portions of cDNA encoding the
peptides sequenced (Fig. 1). The oligonucleotides T3 and T7 hybridize
to the Bluescript phagemid 5' and 3', respectively, to the inserted cDNA sequence. Reagents used to construct the cDNA library were from Stratagene (La Jolla, CA). [
-32P]dATP,
[
-32P]ATP, and [35S]methionine and
Hybond N+ nylon membrane were purchased from Amersham
Pharmacia Biotech. The coupled transcription/translation (TNT) kit was
from Promega (Uppsala, Sweden). The pVL1393 and BaculoGold plasmid and
the transfection kit were obtained from PharMingen (San Diego, CA). High FiveTM cells (BTI-TN-5B1-4) were purchased from Invitrogen (Leek,
The Netherlands). ExCell 401 insect cell medium was from JRH
Biosciences (Lenexa), and TNM-FH insect cell medium was from Sigma.
Restriction enzymes and DNA modification enzymes were obtained from
Promega (Southampton, UK). DNA purification kits were from Qiagen
(Crawley, UK). All other reagents were Analar quality and obtained from
Fisher and Sigma.
Characterization of Native Pholasin--
Native pholasin was
purified using the method of Roberts et al. (8). Pholasin
was subjected to 10% SDS-PAGE and excised, and internal peptides were
generated by in situ trypsin digestion using the method of
Rosenfeld et al. (20). Peptides that appeared pure following
separation by reverse phase high pressure liquid chromatography were
subjected to N-terminal sequencing by Edman degradation on an Applied
Biosystems model 471A Protein Sequenator. The sequence of the N
terminus of the protein was generated by solid state amino acid
sequencing on an Applied Biosystems model 476A Protein Sequencer
(21).
Construction of a cDNA Library--
Pholas light
organs were dissected out of the animals soon after collection and
immediately snap-frozen in liquid nitrogen. Total RNA was purified from
this tissue using the method of Groppe and Morse (22) that was
developed for RNA extraction from molluscan material high in
ribonucleases and mucus. Attempts to purify RNA from light organ tissue
using UltraspecTM reagent (Biotecx) or the method of
Chirgwin et al. (23) resulted in the degradation of the RNA
(data not shown). Messenger RNA (mRNA) was selectively purified
from total RNA using a column of Oligotex beads (Qiagen) according to
the manufacturer's instructions. The cDNA complementary to this
mRNA was generated by oligo(dT)-primed reverse transcription using
the ZAP cDNA synthesis kit (Strategene). A unidirectional library
was constructed in the
ZAP phage.
Generation of Probes and Library Screening--
Degenerate
oligonucleotides were designed from portions of amino acid sequence.
cDNA was produced by reverse transcription of mRNA and
amplified by step down polymerase chain reaction (24) with the
degenerate primers N-term and 2A. This produced a DNA fragment of
approximately 300 base pairs, which was purified by extraction from an
agarose gel. This fragment was subcloned into pGEMT. A positive clone
was selected and sequenced. Non-degenerate oligonucleotide probes were
designed from this cDNA fragment. The cDNA library was screened
with the non-degenerate oligonucleotides according to the method of
Sambrook et al. (25). Positive clones were excised into the
Bluescript phagemid in vivo by simultaneous infection of the
SOLR strain of Escherichia coli with the
vector and the
f1 bacteriophage and were then sequenced in both directions.
Identification of the Gene Encoding Pholasin--
Total genomic
DNA was isolated from whole Pholas organisms following the
methods of Winnepenninckx et al. (26) and Bowtell (27). The
resulting preparations of gDNA were amplified with primers designed
from the cDNA sequence using proofreading polymerases (rTth DNA polymerase XL and BioXAct polymerase,
respectively). The polymerase chain reaction products were purified by
gel extraction (Qiagen) and sequenced in both directions.
Expression and Characterization of the Recombinant
Protein--
A polyclonal antibody was raised in rabbits by
immunization with native pholasin bound to nitrocellulose. Briefly,
native purified protein was fractionated by SDS-PAGE and transferred onto nitrocellulose. The nitrocellulose-containing pholasin was excised
and dissolved in a minimum volume of dimethyl sulfoxide. An equal
volume of sterile phosphate-buffered saline was added, and the
resulting suspension, which constituted the immunogen, was sonicated,
ready for immunization of the rabbits.
Expression in Cell Extracts--
Apoprotein was produced in cell
extracts by coupled in vitro transcription and translation
(TNTTM) of Bluescript clone 40 using T3 polymerase (T3
promoter is included in the plasmid) and rabbit reticulocyte lysate
according to the manufacturer's instructions. Microsomal membranes
were added to the translation mix to perform post-translational
modifications. [35S]Methionine (>1000Ci/mmol) was
included to aid quantification and characterization of the protein by
SDS-PAGE and autoradiography.
Expression in Insect Cells--
Insect cells were maintained and
infected in Excell 401 protein-free medium, pH 6.2, at 27 °C.
BamHI sites were engineered onto the cDNA encoding clone
40 with and without the native signal peptide via polymerase chain
reaction with a proofreading polymerase (BioXAct, Bioline). This
cDNA was subcloned into the BglII site of the pVL1393
vector. Co-transfection of the construct and the BaculoGold plasmid
into HighFive insect cells was performed as described previously (28)
allowing the formation of active virus in vivo. Supernatant
from the virally infected insect cells was used to infect further
flasks of cells for protein production.
The medium was harvested at 4 or 6 days post-infection. The apoprotein
in the medium was precipitated with saturating ammonium sulfate at
4 °C for 1 h, with stirring. This precipitate was pelleted by
centrifugation at 47,800 × g for 30 min at 4 °C.
The pellet was resuspended in 2.5 ml of 50 mM sodium
phosphate, pH 6, and the ammonium sulfate was removed with a PD10
Sephadex column (Amersham Pharmacia Biotech). Cells expressing protein
lacking a signal peptide were pelleted by centrifugation and lysed in
Laemmli buffer. These apoproteins were characterized by SDS-PAGE and
Western blot, probed with the anti-pholasin antibody, detected with
alkaline phosphatase, and quantified by densitometry in comparison with native pholasin.
Extraction of the Luciferin--
As the luciferin may be
unstable, the tissue destined for extraction was snap-frozen
immediately and stored at
70 °C. Five whole P. dactylus
organisms were homogenized in 22.5 ml of 50 mM HEPES, pH
7.5, in a Polytron homogenizer at 4 °C. An equal volume of methanol
(high pressure liquid chromatography grade) and 5 ml of 1 N
HCl were added to the homogenate followed by incubation on ice for
2 h. The resulting particulate material was pelleted by
centrifugation at 47,800 × g for 30 min at 4 °C,
and the supernatant was collected. This supernatant was dried in a
rotatory evaporator, and the residue was resuspended in 5 ml of 50 mM HEPES, pH 7.5. The sample was loaded onto a SEP-PAC
cartridge (Waters) and washed with 5 ml of ethyl acetate. Fractions
eluted with methanol were pooled and dried in a vacuum concentrator and
stored at
70 °C. Prior to a reactivation experiment, the dried
extract was resuspended in 1 ml of HEPES buffer, pH 7.5.
Reactivation of the Recombinant Apoprotein with the Putative
Luciferin--
The secreted apoprotein (10.89 µg in 10 µl) was
incubated for up to 24 h at 4 °C in the presence of 80 µl of
10 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1 mM EDTA, 0.1% gelatin, and 10 mM ascorbate plus 10 µl of the above extracted luciferin. The final pH of the reactivation mixture was 3.5. Controls consisted of buffer, apoprotein, or luciferin extract only. Samples were assayed for chemiluminescence after 0, 1, 2, 6, and 24 h (Fig. 4). Apoprotein reactivated for 18 h as above was loaded onto 0.025-µm MCE filters (Millipore, Bedford, MA) floating on 10 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1 mM EDTA, 0.1% gelatin, and 10 mM ascorbate and incubated at 4 °C (drop dialysis).
Chemiluminescent activity was determined after 18 h. Controls were
native pholasin, apopholasin dialyzed without luciferin, and
non-dialyzed apopholasin stored at 4 °C. Re-addition of luciferin
extract was also investigated to assess the stability of apopholasin
during dialysis. Reactivation at a range of pH from 3 to 6 was also
investigated using 200 mM phosphate/citrate mixtures.
Quantification of Reconstituted Pholasin--
The
chemiluminescence emitted was detected and quantified in a
purpose-built luminometer (1). A 50-µl aliquot of reactivation mix or
controls (sample without apoprotein, without luciferin, or with
neither) was added to 450 µl of 0.1 M sodium barbitone, pH 9, and immediately placed in the luminometer housing. Background light was measured (10 s), and pholasin chemiluminescence was triggered
by the injection of 500 µl of 2% NaOCl. Light emission (counts per
10 s) was monitored for a further 2 min.
 |
RESULTS |
Isolation and Characterization of the Pholasin cDNA--
The
primary Pholas cDNA library contained 106
clones. The non-degenerate oligonucleotide probes hybridized to
2.8 × 10
3% of the plaques of the amplified
library. The positive clones were excised into the Bluescript phagemid
(pBluescript® SK (+/
)), and three clones were completely sequenced
(termed 40, 3, and 5) (Fig. 1). The open
reading frame of these three clones encoded an identical protein of 225 residues from the first methionine to a stop codon. The first
methionine was flanked by a Kozak consensus sequence for the initiation
of translation (29). The protein encoded by these clones contained all
internal peptide sequences determined by sequencing of the native
protein and had the same amino acid composition as the native protein
(30) (Table I). A signal peptide of 20 amino acids was identified between the first methionine and the N
terminus of the mature protein determined by amino acid sequencing. A
neural network trained to identify eukaryotic signal peptides suggested
that the most likely cleavage site is between positions 20 and 21 (GSG-EE), in agreement with the experimental data (31). Three potential
N-linked glycosylation sites with the consensus triplet
sequence Asn-Xaa-(Ser/Thr) (32) have been identified in the protein.
Thr-216 was identified as a potential site of O-linked
glycosylation (33).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 1.
The complete nucleotide and derived amino
acid sequence of clone 40. Partial amino acid sequences
corresponding to tryptic peptides are underlined. The
N-terminal sequence of the purified protein is double
underlined. The numbering of the amino acids is based on the
position of the first predicted methionine. The stop codon is in
bold; an asterisk marks the stop. Amino acids
that are putative N-linked glycosylation sites are shown in
square brackets. A potential O-linked
glycosylation site is shown in parentheses. Bases that are
absent or different in clones 3 or 5 are shown in italics.
Clone 3 had the first two bases missing at the 5' end of the cDNA
and finished at adenosine 804. Clone 5 did not have TATGA at positions
829-833. Both clone 3 and clone 5 have an A-G change at 186, a G-T
change at 534, and a T-C change at position 705. Genomic DNA sequence
was obtained from bases 17 to 832.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
A comparison of the amino acid composition of native pholasin (Henry
and Monny (30)) with the translated composition of the clones isolated
from the cDNA library
|
|
Sequence similarity between the complete recombinant protein and any
known protein in the Swiss-Prot data base was very small (<5%). Small
segments of the protein sequence were also compared against the
sequences in the Swiss-Prot data base using the BLASTP program which
identified several proteins with regions of high sequence similarity to
regions of the cloned protein. These included several proteins that
interact with nucleotides (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Sequence similarities between apopholasin and other proteins
A comparison of the sequence of pholasin with sections of the sequence
of known proteins interact with nucleotides (A). B, Bioluminescent
proteins. An area of high homology between pholasin, Vargula
luciferase, and Renilla LBP is in bold
type.
|
|
The amino acid sequence of the cloned protein was then searched for
known motif sequences by comparison with the PROSITE data base by the
MOTIF algorithm. The sequence of the clones did not contain any of
these signatures present in the PROSITE data base (34). The C terminus,
however, was highly acidic and may bind calcium (35, 36).
The bioluminescent proteins of several bioluminescent organisms have
been cloned. The amino acid sequence of pholasin was compared with the
sequences of these cloned bioluminescent proteins. A small region of
similarity was found between the recombinant protein and the putative
luciferin-binding sites of Vargula luciferase (37) and
Renilla LBP (38) (Table II) but not to any other bioluminescent protein.
The amplification of the pholasin gene from genomic DNA resulted in a
product of the same size as the cDNA. The gDNA sequence was found
be identical to that of clone 40 from the cDNA library (Fig. 1),
indicating the absence of introns.
Expression and Reactivation of Recombinant Pholasin--
The
expression of the protein encoded by clone 40 successfully generated
recombinant apopholasin in cell extracts (Fig.
2), prokaryotic cells (data not shown),
and eukaryotic cells (Fig. 3). The
molecular mass of recombinant pholasin calculated from the amino acid
sequence was 23.5 kDa. The average molecular mass of the unprocessed
protein generated by in vitro transcription and translation
in cell extracts was approximately 26 kDa (Fig. 2). In the presence of
canine microsomal membranes, the molecular mass of the recombinant
protein increased to approximately 34 kDa, the same as that of native
pholasin. Apopholasin lacking a signal peptide remained in the cytosol
of insect cells and had a molecular mass of approximately 26 kDa. The
addition of a signal peptide resulted in the secretion of the protein
into the insect cell medium and an increase of the molecular mass to
approximately 33 kDa. Gels run in the absence of
-mercaptoethanol
revealed the presence of high molecular weight aggregates on Western
blots. Less than 0.1% of the recombinant protein was monomeric on
non-reducing gels. Recombinant apopholasin expressed in E. coli formed inclusion bodies, which were only disrupted in the
presence of 6 M guanidinium hydrochloride, and the removal
of this denaturant caused the reoccurrence of protein aggregation (data
not shown).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
In vitro transcription and
translation of DNA encoding for pholasin. The protein encoded by
clone 40 was generated by in vitro TNT and labeled by the
incorporation of [35S]methionine. The figure shows the
protein products separated by SDS-PAGE and autoradiographed.
Transcription and translation of clone 40 resulted in the generation of
a protein of approximately 26 kDa, which was not present in the
negative controls lacking a template (arrow 1). The addition
of microsomal membranes to the TNT reaction resulted in a processed
protein of approximately 34 kDa (arrow 2).
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblot of insect cell medium harvested 4 days post-infection. Native pholasin 5 (lane 1) and 1 µg (lane 2), 18 µg of recombinant pholasin secreted into
the medium and partially purified (lane 3), or from an
insect cell extract (lane 4) and negative controls, and
medium from insect cells infected with a virus containing C9 cDNA
(lane 5), or uninfected insect cells (lane 6),
were subjected to SDS-PAGE in reducing (blots a and
c) or non-reducing conditions (blot b). Western
blots were probed with the anti-pholasin polyclonal antiserum.
Arrows indicate a dimer of native pholasin and aggregation
of recombinant pholasin in a non-reducing gel.
|
|
The addition of an acid/methanol extract of whole P. dactylus to the recombinant apopholasin resulted in an increase in
chemiluminescence (Fig. 4), indicating
the production of an active protein. Controls using acid/methanol
extract or apoprotein alone, always in the presence of carrier protein,
showed chemiluminescent activity some 4-fold lower than with
apopholasin and luciferin. Furthermore, addition of bovine serum
albumin (0.1%) had no effect on the apopholasin chemiluminescence or
the controls, confirming that the extract containing the putative
luciferin reacted specifically with the apoprotein. However, the
kinetics of the light emitted from the recombinant apopholasin with
luciferin were very different from that of native pholasin. Native
pholasin chemiluminescence triggered by hypochlorite resulted in a
flash, >95% complete within 40 s. In contrast, addition of
hypochlorite to the apopholasin with luciferin resulted in a much
slower chemiluminescence, decaying to half-maximum within 120 s.
The decay was approximately first order (k = 0.006 s
1). Furthermore, there was no detectable difference in
activity at any of the time points (0-24 h). This suggested that,
under these conditions, true photoprotein was not formed. This was
confirmed by drop dialysis, which resulted in 98 ± 1% (mean ± S.E., n = 3) loss in chemiluminescent activity. This
showed that no photoprotein had been formed, since no loss of activity
was detected on drop dialysis of native pholasin. Furthermore,
reactivation of the dialyzed apoprotein with fresh luciferin resulted
in only 15-17% (n = 2) of the apoprotein
chemiluminescence being recovered from the filter.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of hypochlorite-triggered
chemiluminescence. A time course of apopholasin reactivation was
performed by incubating partially purified recombinant pholasin
secreted by insect cells with acid/methanol extract of P. dactylus ( ) for 0 (solid line), 1 (- - -), 2 (- - -), 6 (- -), or 24 h (- -), or incubated without
extract ( ). Controls of buffers only with no apopholasin or
acid/methanol extract ( ) and extract alone ( ) were treated in
identical conditions. Gelatin (0.1%) was present as protein carrier
under all conditions (see "Experimental Procedures").
Chemiluminescence was triggered by the addition of 2% sodium
hypochlorite at 10 s and is shown as chemiluminescent counts minus
background light. A typical curve obtained by hypochlorite triggering
of native pholasin is also shown (×). A representative experiment
carried out in duplicate is shown. E, einstein.
|
|
 |
DISCUSSION |
This paper reports the cloning of the cDNA encoding the
apoprotein responsible for light emission in the luminous bivalve mollusc P. dactylus. Several criteria were used to confirm
that this cDNA did code for apopholasin as follows: the amino acid composition of the recombinant protein and the size of the processed protein matched that of native pholasin, the recombinant protein and
native pholasin are both secreted proteins, and the reactivated recombinant protein is chemiluminescent. The predicted amino acid composition was that previously reported for purified pholasin (Table
I). The fragments of sequence obtained by protein sequencing were
present in the sequence of the recombinant protein. The unprocessed protein had a molecular mass of 26 kDa. However, expression in cell
extracts with microsomal membranes resulted in a protein with a
molecular mass of 34 kDa, the same as that of native pholasin. Furthermore, both the processed and unprocessed protein cross-reacted with antibodies raised to native pholasin. The protein contained glycosylation sites and a putative signal peptide sequence consistent with its identity as a secretory protein. In vitro
transcription-translation in the presence of canine microsomal
membranes, or the targeting of protein to the insect cell secretory
pathway, resulted in an increase in the size of the recombinant protein
likely to be due to glycosylation. Recombinant apopholasin showed a
tendency to aggregate in non-reducing gels. This aggregation may be
caused by the lack of the luciferin, as aequorin is very unstable
without its luciferin (39), or by the high mannose glycosylation, as the recombinant pholasin in the cytosol demonstrated the least aggregation. It is interesting to note that other workers have shown
that the hemagglutinin protein for an influenza strain aggregated when
half the N-linked sugars were incomplete (40), whereas the
unglycosylated protein can fold normally (41). A further explanation
may be that the production of recombinant protein overwhelmed the
chaperones of the cell, as the expression of enzymes such as
protein-disulfide isomerase has increased the expression of active
protein in insect cells (42).
A further finding reported here was the isolation of a small moiety by
acid methanol extraction that can generate light when added to the
recombinant apopholasin (Fig. 4). In native pholasin the luciferin is
tightly bound, probably covalently, to the apoprotein. Muller and
Campbell (43) were successful in extracting a small fluorescent
molecule from native pholasin using butanol.
The kinetics of the light emitted from the recombinant apopholasin with
luciferin were very different from that of native pholasin. Native
pholasin chemiluminescence resulted in a flash, whereas apopholasin
with luciferin resulted in a much slower light emission (Fig. 4). This,
together with the lack of any detectable difference in activity at any
of the time points of reactivation (0-24 h), and complete loss of
chemiluminescence after dialysis, indicated that, under these
conditions, true photoprotein was not formed. The loss of
chemiluminescent activity upon dialysis was the result of both loss of
luciferin (that was not covalently bound) and denaturation of the
apopholasin on the filter. We described a similar loss of activity of
another photoprotein, apo-aequorin, expressed in the cytosol of HeLa
cells which was partially prevented by growing the cells in the
presence of coelenterazine (39).
The apopholasin was therefore acting as a luciferase. Thus there may be
further, as yet unknown, cofactors and chemical events required to form
the full photoprotein. The pH used in the reactivation experiments was
acid. The use of a range of pH showed that an increase in pH from 3 to
6 resulted in a decrease of apopholasin chemiluminescence of 40% (data
not shown). This was not entirely surprising since pholasin is secreted
into the siphon of Pholas, and secretory granules have an
acid pH (44). The fact that the clones had some sequence similarity
with proteins that interact with nucleotides (Table II) may suggest
that pholasin requires a cofactor for reactivation. However, there was
no P-loop binding motif ((A,G)X4GK(S,T) or
(A)X4GK(T)) in the amino acid sequence of these
clones, although not all ATP-binding proteins contain this motif.
Neither did the cloned apoprotein contain the
GXGXXG phosphate binding consensus sequence for
the binding NAD (45). However, it should now be possible to use
reactivation of recombinant apopholasin as an assay to isolate
sufficient luciferin for chemical identification. Apopholasin contained
seven cysteine residues, so there must be at least one free cysteine in
the completely folded active protein, which might contribute to
aggregation via intermolecular disulfide bonds in non-reducing
conditions. In addition, cysteines have been implicated in several
other bioluminescent reactions. Substitution of the cysteine residues
of the photoprotein aequorin with serine resulted in a reduction of
chemiluminescence, possibly as a result of reduced luciferin
(coelenterazine) binding (46). In addition, there was close sequence
homology between the cysteine domains of the luciferases in seven
species of firefly. However, firefly luciferase is active after
cysteine modification (47). It is also interesting to note that
pholasin contains no histidine residues. The C-terminal tryptophan is
unusual in proteins. This, together with a proline eight amino acids
upstream, is consistent with the need to have a solvent cage that
allows oxygen access to the luciferin but protects the excited state generated by the chemiluminescent reaction from quenching by molecules such as oxygen and water in the bulk solvent. GFP exemplifies this
solvent cage principle, requiring a rigid barrel to maintain the
correct physicochemical environment for fluorescence. Based on
mutagenesis experiments (48, 49), we have proposed that in beetle
luciferases and coelenterazine photoproteins the C terminus is a
crucial part of this solvent cage. Like most bioluminescent photoproteins or luciferases, pholasin has a slow maximum turnover number (~0.8 s
1) compared with most enzymes.
No introns were detected in the genomic DNA coding for apopholasin.
This is consistent with findings in the genes of other bioluminescent
proteins where the introns are either very short, as in the luminous
beetles (50), or absent, as in aequorin (51, 52) and both the
luciferase and the LBP of the dinoflagellate Gonyaulax
polyhedra (53, 54).
Luminescence is found in molluscs mainly in 20 squid genera, either as
symbiotic bacteria or generated endogenously (1, 55), but only in two
bivalves, Pholas and Rotocellaria. Five luciferin
families have so far been identified in bioluminescence (1, 56) as
follows: aldehydes; imidazolopyrazines, the most common chemistry
responsible for bioluminescence in the sea; benzothiazole, unique to
luminous beetles; linear tetrapyroles; and flavins. Coelenterazine has
been identified as the luciferin in some squid (57, 58). Although the
small homology of apopholasin with Vargula luciferase and
Renilla luciferin-binding protein might indicate that
pholasin had an imidazolopyrazine luciferin, Muller and Campbell (43)
were unable to reactivate oxypholasin with imidazolopyrazine
luciferins, and no coelenterazine nor Vargula luciferin were
detected in methanol extracts of P. dactylus.
Imidazolopyrazines are proposed to form by cyclization of a tripeptide
(FYY or RIW), similar to fluor formation in GFP (SYG), but with both a
six- and five-membered ring instead of simply the single five-membered imidazo ring in GFP. The possibility, however, existed that some of the
unknown luciferins, including that of pholasin, might be synthesized by
cyclization of other tripeptides. This seemed not to be the case in
Pholas, since no light emission over background was obtained
from apopholasin incubated in the absence of acid methanol extract.
Spectral absorbance suggested a flavin or catechol as the most
promising candidate for pholasin luciferin (43). The evolutionary
origin of bioluminescence presents a considerable challenge for the
Darwinian principle of evolution by natural selection (55, 59). The
current data support the hypothesis that bioluminescence has originated
several times during evolution, since pholasin has no significant
homology with other known bioluminescent proteins. It will be
interesting to examine other non-bioluminescent bivalves to see if they
contain proteins that might show sequence similarity to apopholasin. In
order to generate chemiluminescence that is susceptible to natural
selection, a solvent cage with a high quantum yield is necessary, which
contains a substrate already present in the organism, perhaps as an
antioxidant (60).
The results here provide a basis for discovering the chemical structure
of Pholas luciferin and the evolutionary origin of its
bioluminescence. Furthermore, the ability to express recombinant pholasin in defined compartments of live cells will enable reactive oxygen species to be imaged within individual cells and intact organs
for the first time.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Wilkinson (University of
Liverpool) for sequencing key amino acids for cloning and Dr. C. Van
den Berg (University of Wales College of Medicine) for initial help
with sequencing.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ131051, AJ131052, AJ131053, and AJ131054.
Supported by postgraduate studentships provided by Professor
G. H. Elder, C.B.E., and the University of Wales College of Medicine.
§
Supported by the BHF. Present address: Bristol Heart Institute,
University of Bristol, Bristol Royal Infirmary, BS2 8HW, UK.
¶
To whom correspondence should be addressed. Tel.: 44(0)1222
742951; Fax: 44(0)1222 745440; E-mail: campbellak@cardiff.ac.uk.
1
A. K. Campbell, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
GFP, green fluorescent protein;
PAGE, polyacrylamide gel
electrophoresis;
TNT, coupled in vitro transcription and
translation.
 |
REFERENCES |
| 1.
|
Campbell, A. K.
(1988)
Chemiluminescence: Principles and Applications in Biology and Medicine
, VCH/Horwood, Chichester, UK
|
| 2.
|
Dubois, R.
(1887)
C. R. Soc. Biol.
39,
564-566
|
| 3.
|
Boettcher, K. J.,
Ruby, E. G.,
and McFall Ngai, M. J.
(1996)
J. Comp. Physiol.
179,
65-73
|
| 4.
|
Hastings, J. W.
(1989)
J. Biolumin. Chemilumin.
4,
12-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Nicol, J. A. C.
(1960)
J. Mar. Biol. Assoc.
39,
109-114
|
| 6.
|
Bassot, J.-M.
(1966)
in
Bioluminescence in Progress
(Johnson, F. H.
, and Haneda, Y., eds)
, pp. 559-566, Princeton University Press, Princeton
|
| 7.
|
Henry, J. P.,
Monny, C.,
and Michelson, A. M.
(1975)
Biochemistry
14,
3458-3466[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Roberts, P. A.,
Knight, J.,
and Campbell, A. K.
(1987)
Anal. Biochem.
160,
139-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Michelson, A. M.
(1978)
Methods Enzymol.
57,
385-406
|
| 10.
|
Johnson, F. H.,
and Shimomura, O.
(1978)
Methods Enzymol.
57,
271-291
|
| 11.
|
Cotton, B.,
Allshire, A.,
Cobbold, P. H.,
Muller, T.,
and Campbell, A. K.
(1989)
Biochem. Soc. Trans.
17,
705-706
|
| 12.
|
Cerutti, P. A.
(1985)
Science
227,
375-381[Abstract/Free Full Text]
|
| 13.
|
Markesbery, W. R.
(1997)
Free Radical Biol. & Med.
23,
134-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Johnson, T. M., Yu, Z. X.,
Ferrans, V. J.,
Lowenstein, R. A.,
and Finkel, T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11848-11852[Abstract/Free Full Text]
|
| 15.
|
Korsmeyer, S. J.,
Yin, X. M.,
Oltvai, Z. N.,
Veisnovack, D. J.,
and Linette, G. P.
(1995)
Biochim. Biophys. Acta
1271,
63-66[Medline]
[Order article via Infotrieve]
|
| 16.
|
Finkel, T.
(1998)
Curr. Opin. Cell Biol.
10,
248-253[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Orr, W. C.,
and Sohal, R. S.
(1994)
Science
263,
1128-1130[Abstract/Free Full Text]
|
| 18.
|
Richter, C.
(1995)
Int. J. Biochem. Cell Biol.
27,
647-653[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Wallace, D. C.,
and Melov, S.
(1998)
Nat. Genet.
19,
105-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Rosenfeld, J.,
Capdeville, J.,
Guillemot, J.-C.,
and Ferrara, P.
(1992)
Anal. Biochem.
203,
173-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Findlay, J. B. C.,
Pappin, D. J. C.,
and Keen, J. N.
(1989)
in
Protein Sequencing: A Practical Approach
(Findlay, J. B. C.
, and Geisow, M. J., eds)
, IRL Press at Oxford University Press, Oxford
|
| 22.
|
Groppe, J. C.,
and Morse, D. E.
(1993)
Anal. Biochem.
210,
337-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Chirgwin, J. M.,
Przybyla, A. E.,
MacDonald, R. J.,
and Rutter, W. J.
(1979)
Biochemistry
18,
5294-5299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hecker, K. H.,
and Roux, K. H.
(1996)
BioTechniques
20,
478-485[Medline]
[Order article via Infotrieve]
|
| 25.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 26.
|
Winnepenninckx, B.,
Backeljau, T.,
and Wachter, R. D.
(1993)
Trends Genet.
9,
407[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Bowtell, D. D. L.
(1987)
Anal. Biochem.
163,
391[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Taylor, K. M.,
Morgan, B. P.,
and Campbell, A. K.
(1994)
Immunology
83,
501-506[Medline]
[Order article via Infotrieve]
|
| 29.
|
Kozak, M.
(1991)
J. Biol. Chem.
266,
19867-19870[Free Full Text]
|
| 30.
|
Henry, J. P.,
and Monny, C.
(1977)
Biochemistry
16,
2517-2525[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and Heijne, G. V.
(1997)
Protein Eng.
10,
1-6[Abstract/Free Full Text]
|
| 32.
|
Bause, E.
(1983)
Biochem. J.
209,
331-336[Medline]
[Order article via Infotrieve]
|
| 33.
|
Hansen, J. E.,
Lund, O.,
Engelbrecht, J.,
Bohr, H.,
Neilsen, J. O.,
Hansen, J.-E. S.,
and Brunak, S.
(1995)
Biochem. J.
308,
801-813
|
| 34.
|
Bairoch, A.,
Bucher, P.,
and Hofmann, K.
(1997)
Nucleic Acids Res.
25,
217-221[Abstract/Free Full Text]
|
| 35.
|
Ostwald, T. J.,
MacLennan, D. H.,
and Dorrington, K. J.
(1974)
J. Biol. Chem.
249,
5867-5871[Abstract/Free Full Text]
|
| 36.
|
Ohnishi, M.,
and Reithmeier, R. A.
(1987)
Biochemistry
26,
7458-7465[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Thompson, E. M.,
Nagata, S.,
and Tsuji, F. I.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6567-6571[Abstract/Free Full Text]
|
| 38.
|
Kumar, S.,
Harrylock, M.,
Walsh, K. A.,
Cormier, M. J.,
and Charbonneau, H.
(1990)
FEBS Lett.
268,
287-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Badminton, M. N.,
Sala Newby, G. B.,
Kendall, J. M.,
and Campbell, A. K.
(1995)
Biochem. Biophys. Res. Commun.
217,
950-957[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Hearing, J.,
Gething, M. J.,
and Sambrook, J.
(1989)
J. Cell Biol.
108,
355-365[Abstract/Free Full Text]
|
| 41.
|
Gallager, P. J.,
Henneberry, J. M.,
Sambrook, J. F.,
and Gething, M.-J. H.
(1992)
J. Virol.
66,
7136-7145[Abstract/Free Full Text]
|
| 42.
|
Hsu, T. A.,
Watson, S.,
Eiden, J. J.,
and Betenbaugh, M. J.
(1996)
Protein Expression Purif.
7,
281-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Muller, T.,
and Campbell, A. K.
(1990)
J. Biolumin. Chemilumin.
5,
25-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Tooze, S. A.
(1998)
Biochim. Biophys. Acta
1404,
231-244[Medline]
[Order article via Infotrieve]
|
| 45.
|
Bellamacina, C. A.
(1996)
FASEB J.
10,
1257-1269[Abstract]
|
| 46.
|
Kurose, K.,
Inouye, S.,
Sakaki, Y.,
and Tsuji, T. I.
(1989)
Biochemistry
86,
80-84
|
| 47.
|
Ohmiya, Y.,
and Tsuji, F. I.
(1997)
FEBS Lett.
404,
115-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Sala-Newby, G. B.,
and Campbell, A. K.
(1994)
Biochim. Biophys. Acta
1206,
155-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Watkins, N. J.,
and Campbell, A. K.
(1993)
Biochem. J.
293,
181-185
|
| 50.
|
De Wet, J. R.,
Wood, K. V.,
DeLuca, M.,
Helinski, D. R.,
and Subramani, S.
(1987)
Mol. Cell. Biol.
7,
725-737[Abstract/Free Full Text]
|
| 51.
|
Badminton, M. N.,
Kendall, J. M.,
Sala Newby, G.,
and Campbell, A. K.
(1995)
Exp. Cell Res.
216,
236-243[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Kendall, J. M.,
Dormer, R. L.,
and Campbell, A. K.
(1992)
Biochem. Biophys. Res. Commun.
189,
1008-1016[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Lee, D. H.,
Mittag, M.,
Sczekan, S.,
Morse, D.,
and Hastings, J. W.
(1993)
J. Biol. Chem.
268,
8842-8850[Abstract/Free Full Text]
|
| 54.
|
Li, L. M.,
and Hastings, J. W.
(1998)
Plant Mol. Biol.
36,
275-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Harvey, E. N.
(1952)
Bioluminescence
, Academic Press, New York
|
| 56.
|
Hastings, J. W.
(1996)
Gene (Amst.)
173,
5-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Campbell, A. K.,
and Herring, P. J.
(1990)
Mar. Biol. (New York)
104,
219-225
|
| 58.
|
Thomson, C. M.,
Herring, P. J.,
and Campbell, A. K.
(1997)
J. Biolumin. Chemilumin.
12,
87-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Campbell, A. K.
(1994)
in
Bioluminescence and Chemiluminescence
(Campbell, A. K.
, Kricka, L. J.
, and Stanley, P. E., eds)
, John Wiley & Sons Ltd., Chichester, UK
|
| 60.
|
Rees, J. F.,
DeWergifosse, B.,
Noiset, O.,
Dubuisson, M.,
Janssens, B.,
and Thompson, E. M.
(1998)
J. Exp. Biol.
201,
1211-1221[Abstract]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. J. Swindle, J. A. Hunt, and J. W. Coleman
A Comparison of Reactive Oxygen Species Generation by Rat Peritoneal Macrophages and Mast Cells Using the Highly Sensitive Real-Time Chemiluminescent Probe Pholasin: Inhibition of Antigen-Induced Mast Cell Degranulation by Macrophage-Derived Hydrogen Peroxide
J. Immunol.,
November 15, 2002;
169(10):
5866 - 5873.
[Abstract]
[Full Text]
[PDF]
|
 |
|